Aspirin and Carotid Endarterectomy Trial "ACE"


Phase N/A Results

Eligibility Criteria

Inclusion Criteria

Patients scheduled for endarterectomy for arteriosclerotic disease and tolerant of 1300 mg acetylsalicylic acid daily.

Exclusion Criteria

Participation in another trial, requiring acetylsalicylic acid or other antiplatelet medication prior to study, recent disabling stroke, cardiac surgery in previous 30 days or scheduled for cardiac surgery in the next 30 days, failure to provide informed consent.